Integral Diagnostics Hisse

Integral Diagnostics Net Marj

Integral Diagnostics (IDX.AX) öğesinin Net Kar Marjı değeri 25 Ağu 2026 itibarıyla 0,74 % dir. Önceki yılda, Net Kar Marjı -12,92 % idi — -105,76% (daha yüksek) bir değişiklik.

Net Marj

0,74 %

YoY

-105,76%

Son güncelleme:

Integral Diagnostics öğesinin Net Kar Marjı değeri 2026 0,74 % dir. Integral Diagnostics öğesinin Net Kar Marjı değeri 2025 -12,92 % idi. %-105,76 daha yüksek önceki yıla kıyasla azalmaktadır.

Integral Diagnostics için net marj, %0,7 ile birkaç yıl önceki %8,9 seviyesine göre geriledi.

Integral Diagnostics Net Marj Tarihçesi

  • 3 yıl

  • 10 yıl

  • 25 Yıl

  • Maks.

Net Marj
Date
Net Marj
1 Oca 2018
7,95 AUD
1 Oca 2019
9,03 AUD
1 Oca 2020
8,36 AUD
1 Oca 2021
8,92 AUD
1 Oca 2022
4,05 AUD
1 Oca 2023
5,68 AUD
1 Oca 2024
-12,92 AUD
1 Oca 2025
0,74 AUD
Integral Diagnostics Net Marj Tarihçesi
YILNet MarjYoY
0,74 %-105,76%
-12,92 %-327,49%
5,68 %+40,41%
4,05 %-54,62%
8,92 %+6,67%
8,36 %-7,43%
9,03 %+13,61%
7,95 %-7,53%
8,60 %+26,82%
6,78 %+128,02%
2,97 %-70,47%
10,07 %+10.376,86%
0,10 %
Access this data via the Eulerpool API

Integral Diagnostics Hisse senedi analizi

Integral Diagnostics ne yapar? Integral Diagnostics Ltd is an Australian company that has been providing medical imaging services for over 25 years. The company was founded in 1994 by Dr. Ian Kadish and a team of radiologists in Perth, Western Australia, offering radiology services to local clinics and hospitals. Over the years, Integral Diagnostics has expanded its services to provide imaging services nationwide. The business model of Integral Diagnostics is to deliver medical imaging to enable doctors and their patients to have a fast and accurate diagnosis. The company offers imaging services for a variety of medical specialties, including radiology, cardiology, obstetrics and gynecology, and neurology. They operate over 49 locations in Australia, many of which are in rural areas where access to medical care may be limited. Integral Diagnostics offers a wide range of products based on medical imaging. These include X-rays, mammography, ultrasound, CT scans, MRI scans, PET scans, and bone density scans. The company takes pride in being one of the few Australian medical imaging companies to offer a complete range of imaging services. Their services are conducted by qualified radiologists specialized in interpreting medical images. Integral Diagnostics also operates clinics for performing diagnostic and therapeutic procedures such as biopsies, drainages, and injections. These procedures are carried out by highly qualified radiologists to provide patients with faster and more accurate diagnoses. Integral Diagnostics is committed to quality assurance and has a comprehensive quality management system that is annually reviewed by independent auditors. The company is accredited by both the Australian Medical Association and the Australian National Accreditation Scheme (NATA). These accreditations recognize the high standards that Integral Diagnostics sets for delivering medical imaging services. One of Integral Diagnostics' recent activities is their use of artificial intelligence (AI) in image interpretation. The company has partnered with MaxQ AI, a leading provider of AI solutions for medical imaging. Through this partnership, Integral Diagnostics doctors can utilize the latest AI tools to improve their patients' diagnoses. Integral Diagnostics is a strong advocate for social justice and is dedicated to supporting disadvantaged communities in Australia. The company has partnered with nonprofit organizations such as the National Breast Cancer Foundation, The Smith Family, and the Friendship Foundation. Overall, Integral Diagnostics has undergone impressive growth over the past 25 years and is now a leading Australian medical imaging company. With a wide range of imaging services and a strong focus on quality and social responsibility, the company is well-positioned to continue its success in the future. Integral Diagnostics, Eulerpool'daki en popüler şirketlerden biridir.

Integral Diagnostics hisse senedi hakkında sık sorulan sorular

Integral Diagnostics şirketinin Net Kar Marjı değeri 2026 yılında 0,74 %.

Integral Diagnostics öğesinin Net Kar Marjı değeri -12,92 % değerinden 0,74 % değerine değişmiş ve bu %-105,76 değişimi temsil etmektedir. Değer önceki yıldan daha yüksek dir.

Eulerpool'da Net Kar Marjı öğesinin Integral Diagnostics değerinin 2006'dan itibaren tam tarihsel gelişimini bulabilirsiniz — yıllık değerler, grafikler ve ayrıntılı analiz ile.

Net kar marjı, tüm giderler sonrasında gelirin yüzde kaçının net kar olarak kaldığını ölçer ve bir şirketin karlılığının nihai göstergesidir.

İyi bir değeri endüstriye ve şirketin aşamasına göre değişir. Eulerpool'da, Net Kar Marjı'nin Integral Diagnostics değerini sektör emsalleriyle ve endüstri ortalamasıyla karşılaştırarak cazip olup olmadığını değerlendirebilirsiniz.

Net Kar Marjı'nin değerini değerlendirmek için, aynı endüstri ve sektördeki emsalleriyle karşılaştırması önemlidir. Eulerpool'da Net Kar Marjı için doğrudan endüstri karşılaştırmaları bulabilirsiniz.

Access this data via the Eulerpool API

Marjlar — Integral Diagnostics

Tüm Kilit Metrikler — Integral Diagnostics